Prospective study will evaluate safety and efficacy of the Zoom 88 Large Distal Platform for aspiration within eight hours of stroke onset CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. announced today that the first patient has been enrolled in the Imperative Trial. This prospective, multi-center clinical trial is the first study designed […]
Other News
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
Fiscal 2022 First Quarter Highlights Net sales of $77.0 million increased 9.6% compared to the prior-year quarter Gross margin of 52.1% increased 120 basis points year over year GAAP loss per share of $0.18, and adjusted loss per share of $0.02 The Company commenced a Limited Market Release of its […]
Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient has been successfully treated with its ViperCross peripheral support catheter. Dr. Billy J. Kim, MD, The […]
FDA Clears First Major Imaging Device Advancement for Computed Tomography in Nearly a Decade
SILVER SPRING, Md., Sept. 30, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly a decade. “Computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality; planning and guiding interventional or […]
UltraSight Collaboration with GE Healthcare will bring Wireless Cardiac Point of Care Ultrasound to Space
Technology developed through partnership to monitor astronaut’s heart during ‘Rakia’ space mission CHICAGO and TEL AVIV, ISRAEL, Sept. 30, 2021 /PRNewswire/ — UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI, announced a new collaboration with GE Healthcare to conduct a cardiac study aboard the Axiom ‘Rakia’ space mission, and the successful completion […]
Picard Medical, Inc. Acquires Mechanical Heart Replacement Technology
PALO ALTO, Calif., Sept. 30, 2021 /PRNewswire/ — Picard Medical, Inc (“Picard”), a portfolio company of Hunniwell Lake Ventures, LLC, today announced that it has acquired SynCardia Systems, LLC (“SynCardia”), the global leader in mechanical heart replacement technology. Heart disease continues to be the number one cause of death globally, with the […]
Match Health Academy Launches Innovative Video-Based Courses on Atrial Fibrillation (AFib)
SANTA CLARA, Calif., Sept. 30, 2021 /PRNewswire/ — Match Health Academy has launched three online, expert-guided, video-based courses designed to help patients and their families better understand and manage AFib. The three courses offered include: AFib Essentials, The Ultimate Guide to Afib Nutrition and The Ultimate Guide to Yoga for AFib. The courses are designed to […]
BioAdvance Announces ~$7M in Recent Investments and Leadership Transition
Barbara Schilberg retiring as Managing Director and CEO; Shahram Hejazi, Ph.D., appointed as Managing Director and CEO PHILADELPHIA, Sept. 29, 2021 /PRNewswire/ — BioAdvance, a $70 million early-stage life sciences fund with a focus in the mid-Atlantic region, announced today that it has added six new companies to its portfolio in the last 18 months and […]
Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
September 30, 2021 Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim Amsterdam, the Netherlands and Philadelphia, PA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Lankenau Heart Institute part of Main Line Health, today announced they […]
Merck to Acquire Acceleron Pharma Inc.
Acquisition Complements and Strengthens Merck’s Cardiovascular Pipeline Sotatercept is a Potentially First-In-Class Therapy in Phase 3 Development for the Treatment of Pulmonary Arterial Hypertension REBLOZYL® (luspatercept-aamt) is a First-In-Class Erythroid Maturation Recombinant Fusion Protein Approved for the Treatment of Anemia in Certain Rare Blood Disorders Merck to Host Investor Call at […]



